MRIGlobal Dx's mission is to enable the commercialization of diagnostics for improved patient outcomes.
MRIGlobal Dx provides laboratory services for CLIA-certified laboratories and
in vitro diagnostics developers.
Let MRIGlobal Dx accelerate your timeline and expand your test menu with our high quality, customized service. From early product development to FDA or CE-IVD approval, we provide scientific and laboratory services for the development of molecular diagnostic products.
In The News
Recent Press Releases/Event
MRIGlobal Announces NREL Innovations Win
MRIGlobal Recognized as an American Heart Association Fit-Friendly Worksite
MRIGlobal Awarded $63 Million Contract for National Toxicology Program
U.S. Ambassador Robert Mikulak Named to Receive 2014 MRIGlobal Citation 5.27.2014
Thomas M. Sack Named to Kansas City Area Life Sciences Board of Directors
Society of Toxicology Recognizes MRIGlobal for 25 Years of Support at Annual Conference